These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 365536)

  • 21. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F; Braun B; Klaus D; Lemke R; Zehner J
    Dtsch Med Wochenschr; 1976 Oct; 101(41):1482-8. PubMed ID: 183943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-daily propranolol for hypertension.
    Lopez LM; Gefter ML; Hemmes RJ
    Drug Intell Clin Pharm; 1984 Oct; 18(10):812-5. PubMed ID: 6489162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methyldopa and propranolol or practolol in moderate hypertension.
    Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
    Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol in the control of blood pressure: a dose-response study.
    Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
    Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
    Davidov M
    Am Heart J; 1985 May; 109(5 Pt 2):1158-67. PubMed ID: 2859780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
    Carter BL; Gersema LM; Williams GO; Schabold K
    Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
    Gavras I; Gavras H; Sullivan PC; Tifft CP; Chobanian AV; Brunner HR
    J Clin Pharmacol; 1979 Jan; 19(1):8-14. PubMed ID: 368088
    [No Abstract]   [Full Text] [Related]  

  • 32. Double blind study with propranolol in the treatment of hypertension.
    De Tollenaere G
    Brux Med; 1973 Nov; Spec No(0):99-110. PubMed ID: 4609568
    [No Abstract]   [Full Text] [Related]  

  • 33. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
    Vandongen R; Beilin LJ; Lalor C; Wall BP
    Aust N Z J Med; 1982 Oct; 12(5):473-7. PubMed ID: 6758744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive efficacy of propranolol given twice daily.
    MacLeod SM; Hamet P; Kaplan H; Larochelle P; Nadeau J; Ogilvie RI; Rangno RE; Ruedy J; Sellers EM; Ti TY
    Can Med Assoc J; 1979 Sep; 121(6):737-40. PubMed ID: 391380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension.
    Seedat YK
    S Afr Med J; 1979 Dec; 56(23):983-6. PubMed ID: 399093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.
    Danielsson A; Bjerle P; Ek B; Steen L; Suhr O
    Eur J Clin Pharmacol; 1987; 33(1):15-20. PubMed ID: 3319637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of acebutolol and propranolol in essential hypertension.
    Wahl J; Turlapaty P; Singh BN
    Am Heart J; 1985 Feb; 109(2):313-21. PubMed ID: 3880995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oral MK-421 and propranolol on the forearm arterial circulation in essential hypertension: a preliminary report.
    Levenson JA; Safar ME; Simon AC; Maarek BE
    J Hypertens Suppl; 1983 Oct; 1(1):101-2. PubMed ID: 6100597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.